Delivery Order SPE2DB20D3303-SPE2DB25FA0EZ
Award Date
6/13/25
Potential Completion Date
6/16/25
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,963.90 firm fixed-price contract is for the supply of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REXULTI 0.5 MG TABLET 30S. The contract has a ceiling value of $30,712.23 and a completion date of February 14, 2025. It is a firm fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a prescription medication, with a ceiling value of $1,951.94 and a period of performance through April 28, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $37,571.13 and is a firm-fixed price arrangement with an ultimate completion date of August 23, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which is valued at up to $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,469.78 firm fixed-price contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 0.5 MG TABLET 30S, a prescription medication. The award has a firm fixed price, a ceiling value of $6,103.11, and an ultimate completion date of June 5, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a firm fixed price of $16,951.34 and a completion date of June 10, 2025. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,230.60 and a period of performance through April 29, 2025. The contract is a firm-fixed-price delivery order, which indicates that the pricing is pre-determined. The contract is not set aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,358.92, is for the delivery of REXULTI 1 mg tablets. The contract has a completion date of March 31, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $1,713.31 and has an ultimate completion date of April 29, 2025. The award is for the supply of 4568060947 - REXULTI 0.25 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop...